Wells Fargo
RLAY icon

Wells Fargo’s Relay Therapeutics RLAY Stock Holding History

Wells Fargo’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.81M Buy
203,737
+93,785
+85% +$1.36M ﹤0.01% 3092
2026
Q1 		$1.09M Sell
109,952
-47,940
-30% -$429K ﹤0.01% 3687
2025
Q4 		$1.34M Buy
157,892
+56,352
+55% +$402K ﹤0.01% 3744
2025
Q3 		$530K Buy
101,540
+16,560
+19% +$63.1K ﹤0.01% 4267
2025
Q2 		$294K Buy
84,980
+9,466
+13% +$28.2K ﹤0.01% 4511
2025
Q1 		$198K Buy
75,514
+4,089
+6% +$16K ﹤0.01% 4709
2024
Q4 		$294K Sell
71,425
-59,042
-45% -$321K ﹤0.01% 4544
2024
Q3 		$924K Buy
130,467
+86,662
+198% +$647K ﹤0.01% 3593
2024
Q2 		$286K Buy
43,805
+10,274
+31% +$70.2K ﹤0.01% 4270
2024
Q1 		$278K Buy
33,531
+5,682
+20% +$55.4K ﹤0.01% 4262
2023
Q4 		$307K Sell
27,849
-63,741
-70% -$538K ﹤0.01% 4203
2023
Q3 		$770K Sell
91,590
-49,651
-35% -$534K ﹤0.01% 3503
2023
Q2 		$1.77M Buy
141,241
+51,516
+57% +$641K ﹤0.01% 3016
2023
Q1 		$1.48M Buy
89,725
+88,819
+9,803% +$1.59M ﹤0.01% 3115
2022
Q4 		$13.5K Sell
906
-1,727
-66% -$33.1K ﹤0.01% 5424
2022
Q3 		$59K Sell
2,633
-748
-22% -$16.4K ﹤0.01% 4876
2022
Q2 		$56K Sell
3,381
-20,713
-86% -$444K ﹤0.01% 4970
2022
Q1 		$721K Sell
24,094
-22,726
-49% -$551K ﹤0.01% 4141
2021
Q4 		$1.44M Sell
46,820
-3,646
-7% -$115K ﹤0.01% 3811
2021
Q3 		$1.59M Buy
50,466
+19,867
+65% +$669K ﹤0.01% 3865
2021
Q2 		$1.12M Buy
30,599
+20,779
+212% +$685K ﹤0.01% 4134
2021
Q1 		$340K Sell
9,820
-13,386
-58% -$581K ﹤0.01% 4898
2020
Q4 		$964K Sell
23,206
-9,810
-30% -$443K ﹤0.01% 4059
2020
Q3 		$1.41M Buy
+33,016
New +$1.26M ﹤0.01% 3604

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Wells Fargo's RLAY Position: Q2 2026 in Review

Wells Fargo increased its Relay Therapeutics (RLAY) stake by 85% in Q2 2026, buying an estimated $1.36M and bringing the position to 203,737 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Wells Fargo first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Wells Fargo held 203,737 shares of Relay Therapeutics worth $3.81M as of Q2 2026.
  • Wells Fargo bought 93,785 Relay Therapeutics shares in Q2 2026, an estimated $1.36M.
  • Relay Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3092 holding.
  • Wells Fargo first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.